مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

880
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

1

Information Journal Paper

Title

ASSESSMENT OF THE EFFECT OF COMBINATION THERAPY WITH DEFERIPRONE & DESFERRIOXAMINE ON CARDIAC COMPLICATIONS IN MAJOR THALASSEMIA

Pages

  12-19

Abstract

 Background and Purpose: Cardiac complications in major thalassernia are the most debilitating problem among them. Iron chelating with DESFERRIOXAMINE, may be difficult or inadequate. The aim of this research is to evaluate the effect of combination therapy with the two drugs "deferiprone & DESFERRIOXAMINE" on cardiac complications in major thalassernia.Materials and Methods: In a clinical trial study (before & after), 47(24men and 23 women) patients with major THALASSEMIA referred to Booali research center, 10 to 35 years old, all of whom were undertaken combination therapy with DEFERIPRONE & DESFERRIOXAMINE, enrolled in this study.Echocardiography was performed for all patients before & after at least 6 months of combination therapy. Echocardiographic systolic & diastolic function indices including LVEF, EPSS, CI&E/A, EF slope & MPI, as well as presence of arrhythmia were obtained. The data were analyzed by paired T Test & Pearson correlation.Results: There were significant changes in ferritin, systolic function& MPI, indicating statistically significant improvement. Ferritin decreased to 3306±1347 ng/ml from 4489±1607 ng/ml (p=0.0001). VEF increased to 69.7±2.6% from 67.6±3.9% (p=0.04). EPSS decreased to 2.9±1.3mm from 3.9±2.lmm (p=0.004). Cardiac Index increased to 3.6±0.18 from 3.5±0.3 (p=0.02). MPI decreased to 0.33±0.05 from 0.37±0.06 (p=0.03). Arrhythmia & diastolic function were also slightly improved which were statistically no significant.Conclusion: The results showed that combination therapy with the two drugs DEFERIPRONE & DESFERRIOXAMINE led to decrease ferritin level and improve systolic function in patients with major THALASSEMIA.

Cites

References

  • No record.
  • Cite

    APA: Copy

    RASHIDI GHADER, F., KOUSARIAN, M., & KARAMI, HOSSEIN. (2008). ASSESSMENT OF THE EFFECT OF COMBINATION THERAPY WITH DEFERIPRONE & DESFERRIOXAMINE ON CARDIAC COMPLICATIONS IN MAJOR THALASSEMIA. JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES, 17(61), 12-19. SID. https://sid.ir/paper/45899/en

    Vancouver: Copy

    RASHIDI GHADER F., KOUSARIAN M., KARAMI HOSSEIN. ASSESSMENT OF THE EFFECT OF COMBINATION THERAPY WITH DEFERIPRONE & DESFERRIOXAMINE ON CARDIAC COMPLICATIONS IN MAJOR THALASSEMIA. JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2008;17(61):12-19. Available from: https://sid.ir/paper/45899/en

    IEEE: Copy

    F. RASHIDI GHADER, M. KOUSARIAN, and HOSSEIN KARAMI, “ASSESSMENT OF THE EFFECT OF COMBINATION THERAPY WITH DEFERIPRONE & DESFERRIOXAMINE ON CARDIAC COMPLICATIONS IN MAJOR THALASSEMIA,” JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES, vol. 17, no. 61, pp. 12–19, 2008, [Online]. Available: https://sid.ir/paper/45899/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top